| No. |
KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * |
DrugBank |
Disease ID * [Number of diseases] |
| 1 | Acute myeloid leukemia 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 2 | Adipocytokine signaling pathway 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 3 | AGE-RAGE signaling pathway in diabetic complications 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 4 | Aldosterone-regulated sodium reabsorption 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 5 | Alzheimer disease 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 6 | Amoebiasis 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 7 | Amphetamine addiction 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 8 | AMPK signaling pathway 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 9 | Amyotrophic lateral sclerosis (ALS) 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 10 | Apelin signaling pathway 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 11 | Apoptosis 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 12 | Autophagy - animal 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 13 | Autophagy - other 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 14 | Axon guidance 6 genes, 3 drugs (DrugBank), 56 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 15 | B cell receptor signaling pathway 8 genes, 5 drugs (DrugBank), 56 diseases shown |
[1] BTK |
D10223 |
Ibrutinib |
[2] 28, 61 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 16 | Bacterial invasion of epithelial cells 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 17 | Breast cancer 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 18 | C-type lectin receptor signaling pathway 7 genes, 4 drugs (DrugBank), 56 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 19 | Calcium signaling pathway 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 20 | cAMP signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 21 | Carbohydrate digestion and absorption 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 22 | Cell adhesion molecules (CAMs) 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 23 | Cellular senescence 7 genes, 4 drugs (DrugBank), 72 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 24 | Central carbon metabolism in cancer 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 25 | cGMP-PKG signaling pathway 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 26 | Chagas disease (American trypanosomiasis) 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 27 | Chemokine signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 28 | Choline metabolism in cancer 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 29 | Cholinergic synapse 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 30 | Chronic myeloid leukemia 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 31 | Colorectal cancer 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 32 | Complement and coagulation cascades 3 genes, 2 drugs (DrugBank), 1 disease shown |
[3] C1R, C1S, KLKB1 |
D10845 |
Conestat alfa |
[1] 61 |
| [1] C1S |
D11530 |
Sutimlimab |
[1] 61 |
| 33 | Dopaminergic synapse 3 genes, 2 drugs (DrugBank), 55 diseases shown |
[3] PPP3CA, PPP3CB, PPP3CC |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 34 | Drug metabolism - other enzymes 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] RRM1 |
D01907 |
Fludarabine |
[17] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 35 | EGFR tyrosine kinase inhibitor resistance 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 36 | Endocrine resistance 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 37 | Endometrial cancer 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 38 | Epstein-Barr virus infection 4 genes, 4 drugs (DrugBank), 12 diseases shown |
[1] BTK |
D10223 |
Ibrutinib |
[2] 28, 61 |
| [1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 39 | ErbB signaling pathway 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 40 | Estrogen signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 41 | Fc epsilon RI signaling pathway 3 genes, 3 drugs (DrugBank), 7 diseases shown |
[1] BTK |
D10223 |
Ibrutinib |
[2] 28, 61 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 42 | Fc gamma R-mediated phagocytosis 2 genes, 2 drugs (DrugBank), 6 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 43 | Fluid shear stress and atherosclerosis 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 44 | Focal adhesion 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 45 | FoxO signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 46 | Gap junction 9 genes, 1 drug (DrugBank), 4 diseases shown |
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D02197 |
Vincristine |
[4] 26, 34, 61, 331 |
| D08679 |
| 47 | Gastric cancer 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 48 | Glioma 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 49 | Glucagon signaling pathway 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 50 | Glutamatergic synapse 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 51 | Glutathione metabolism 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] RRM1 |
D01907 |
Fludarabine |
[17] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 52 | GnRH secretion 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 53 | Growth hormone synthesis, secretion and action 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 54 | Hematopoietic cell lineage 1 gene, 1 drug (DrugBank), 42 diseases shown |
[1] MS4A1 |
D02994 |
Rituximab |
[42] 11, 13, 14, 17, 35, 36, 43, 44, 45, 46, 49, 50, 51, 52, 53, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 222, 223, 229, 256, 271, 283, 284, 285, 288, 300, 331 |
| 55 | Hepatitis B 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 56 | Hepatitis C 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 57 | Hepatocellular carcinoma 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 58 | Herpes simplex virus 1 infection 3 genes, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 59 | HIF-1 signaling pathway 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 60 | Human cytomegalovirus infection 7 genes, 4 drugs (DrugBank), 72 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 61 | Human immunodeficiency virus 1 infection 7 genes, 4 drugs (DrugBank), 72 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 62 | Human papillomavirus infection 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 63 | Human T-cell leukemia virus 1 infection 7 genes, 4 drugs (DrugBank), 57 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 64 | Inflammatory mediator regulation of TRP channels 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 65 | Influenza A 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 66 | Inositol phosphate metabolism 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 67 | Insulin resistance 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 68 | Insulin signaling pathway 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 69 | JAK-STAT signaling pathway 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 70 | Kaposi sarcoma-associated herpesvirus infection 8 genes, 5 drugs (DrugBank), 72 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 71 | Leukocyte transendothelial migration 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 72 | Long-term potentiation 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 73 | Longevity regulating pathway 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 74 | Longevity regulating pathway - multiple species 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 75 | Malaria 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 76 | MAPK signaling pathway 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 77 | Measles 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 78 | Melanoma 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 79 | Metabolic pathways 2 genes, 2 drugs (DrugBank), 19 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [1] RRM1 |
D01907 |
Fludarabine |
[17] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 80 | MicroRNAs in cancer 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 81 | mTOR signaling pathway 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 82 | Natural killer cell mediated cytotoxicity 8 genes, 5 drugs (DrugBank), 57 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 83 | Neuroactive ligand-receptor interaction 1 gene, 2 drugs (DrugBank), 53 diseases shown |
[1] NR3C1 |
D00472 |
Prednisolone |
[38] 11, 13, 25, 26, 35, 38, 39, 41, 43, 44, 45, 46, 49, 50, 51, 56, 60, 61, 63, 64, 65, 66, 75, 81, 84, 85, 95, 96, 97, 113, 145, 162, 222, 269, 271, 296, 299, 300 |
| D00980 |
| D00981 |
| D00982 |
| D01239 |
| D01998 |
| D02156 |
| D03301 |
| D00473 |
Prednisone |
[44] 2, 11, 13, 14, 26, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 61, 63, 64, 65, 66, 81, 84, 85, 86, 95, 96, 97, 113, 145, 162, 164, 222, 224, 228, 251, 283, 284, 285, 288, 299, 300, 331 |
| 84 | Neurotrophin signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 85 | NF-kappa B signaling pathway 2 genes, 2 drugs (DrugBank), 5 diseases shown |
[1] BTK |
D10223 |
Ibrutinib |
[2] 28, 61 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 86 | Non-alcoholic fatty liver disease (NAFLD) 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 87 | Non-small cell lung cancer 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 88 | Oocyte meiosis 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 89 | Osteoclast differentiation 8 genes, 5 drugs (DrugBank), 56 diseases shown |
[1] BTK |
D10223 |
Ibrutinib |
[2] 28, 61 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 90 | Oxytocin signaling pathway 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 91 | Pancreatic cancer 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 92 | Pathogenic Escherichia coli infection 9 genes, 1 drug (DrugBank), 4 diseases shown |
[9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D02197 |
Vincristine |
[4] 26, 34, 61, 331 |
| D08679 |
| 93 | Pathways in cancer 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 94 | PD-L1 expression and PD-1 checkpoint pathway in cancer 7 genes, 4 drugs (DrugBank), 72 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 95 | Pertussis 2 genes, 2 drugs (DrugBank), 1 disease shown |
[2] C1R, C1S |
D10845 |
Conestat alfa |
[1] 61 |
| [1] C1S |
D11530 |
Sutimlimab |
[1] 61 |
| 96 | Phagosome 10 genes, 2 drugs (DrugBank), 4 diseases shown |
[1] C1R |
D10845 |
Conestat alfa |
[1] 61 |
| [9] TUBB, TUBB1, TUBB2A, TUBB2B, TUBB3, TUBB4A, TUBB4B, TUBB6, TUBB8 |
D02197 |
Vincristine |
[4] 26, 34, 61, 331 |
| D08679 |
| 97 | Phosphatidylinositol signaling system 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 98 | Phospholipase D signaling pathway 3 genes, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 99 | PI3K-Akt signaling pathway 3 genes, 3 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 100 | Platelet activation 3 genes, 3 drugs (DrugBank), 7 diseases shown |
[1] BTK |
D10223 |
Ibrutinib |
[2] 28, 61 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 101 | Platinum drug resistance 3 genes, 2 drugs (DrugBank), 8 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [2] TOP2A, TOP2B |
D03899 |
Doxorubicin |
[6] 26, 28, 34, 61, 63, 331 |
| 102 | Primary immunodeficiency 1 gene, 1 drug (DrugBank), 2 diseases shown |
[1] BTK |
D10223 |
Ibrutinib |
[2] 28, 61 |
| 103 | Progesterone-mediated oocyte maturation 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 104 | Prolactin signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 105 | Prostate cancer 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 106 | Proteasome 1 gene, 2 drugs (DrugBank), 15 diseases shown |
[1] PSMB5 |
D03150 |
Bortezomib |
[13] 11, 26, 28, 46, 49, 51, 61, 63, 66, 228, 256, 288, 331 |
| D10130 |
Ixazomib |
[4] 13, 16, 28, 61 |
| 107 | Proteoglycans in cancer 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 108 | Purine metabolism 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] RRM1 |
D01907 |
Fludarabine |
[17] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 109 | Pyrimidine metabolism 1 gene, 1 drug (DrugBank), 17 diseases shown |
[1] RRM1 |
D01907 |
Fludarabine |
[17] 13, 28, 36, 46, 49, 51, 60, 61, 62, 65, 85, 96, 164, 283, 284, 285, 326 |
| D07966 |
| 110 | Rap1 signaling pathway 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 111 | Ras signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 112 | Regulation of actin cytoskeleton 2 genes, 2 drugs (DrugBank), 10 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 113 | Regulation of lipolysis in adipocytes 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 114 | Relaxin signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 115 | Renal cell carcinoma 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 116 | Renin secretion 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 117 | Rheumatoid arthritis 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 118 | Shigellosis 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 119 | Signaling pathways regulating pluripotency of stem cells 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 120 | Small cell lung cancer 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 121 | Sphingolipid signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 122 | Staphylococcus aureus infection 3 genes, 3 drugs (DrugBank), 9 diseases shown |
[2] C1R, C1S |
D10845 |
Conestat alfa |
[1] 61 |
| [1] C1S |
D11530 |
Sutimlimab |
[1] 61 |
| [1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 123 | Systemic lupus erythematosus 2 genes, 2 drugs (DrugBank), 1 disease shown |
[2] C1R, C1S |
D10845 |
Conestat alfa |
[1] 61 |
| [1] C1S |
D11530 |
Sutimlimab |
[1] 61 |
| 124 | T cell receptor signaling pathway 6 genes, 3 drugs (DrugBank), 56 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 125 | Th1 and Th2 cell differentiation 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 126 | Th17 cell differentiation 6 genes, 3 drugs (DrugBank), 72 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 127 | Thermogenesis 1 gene, 1 drug (DrugBank), 36 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| 128 | Thyroid hormone signaling pathway 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 129 | TNF signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 130 | Toll-like receptor signaling pathway 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 131 | Tuberculosis 6 genes, 3 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 132 | Type II diabetes mellitus 2 genes, 2 drugs (DrugBank), 37 diseases shown |
[1] MTOR |
D00753 |
Sirolimus |
[36] 2, 13, 15, 17, 34, 35, 36, 46, 49, 51, 60, 61, 62, 63, 65, 66, 67, 85, 86, 89, 96, 98, 137, 157, 158, 192, 222, 256, 277, 278, 279, 280, 281, 283, 285, 331 |
| [1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| 133 | VEGF signaling pathway 6 genes, 3 drugs (DrugBank), 56 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 134 | Viral carcinogenesis 2 genes, 2 drugs (DrugBank), 6 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |
| [1] SYK |
D09347 |
Fostamatinib |
[4] 46, 49, 61, 66 |
| 135 | Viral myocarditis 1 gene, 1 drug (DrugBank), 9 diseases shown |
[1] ITGAL |
D03959 |
Efalizumab |
[9] 11, 13, 37, 46, 49, 53, 61, 95, 96 |
| 136 | Wnt signaling pathway 5 genes, 2 drugs (DrugBank), 55 diseases shown |
[5] PPP3CA, PPP3CB, PPP3CC, PPP3R1, PPP3R2 |
D00184 |
Ciclosporin |
[44] 11, 14, 19, 20, 26, 28, 36, 38, 39, 40, 41, 42, 45, 46, 49, 50, 53, 55, 56, 58, 60, 61, 62, 63, 64, 65, 90, 95, 97, 113, 162, 164, 222, 223, 226, 228, 234, 269, 274, 283, 284, 285, 302, 326 |
| D00107 |
Tacrolimus |
[30] 2, 11, 13, 36, 46, 49, 50, 51, 53, 60, 61, 62, 65, 66, 85, 86, 95, 96, 97, 113, 151, 158, 164, 222, 224, 226, 228, 283, 284, 299 |
| D08556 |
| 137 | Yersinia infection 1 gene, 1 drug (DrugBank), 3 diseases shown |
[1] PIK3CD |
D11437 |
Parsaclisib |
[3] 35, 53, 61 |